Novel Biomarkers of SLE with Renal and Neuropsychiatry Complications

SLE is a complex multi-organ autoimmune disease exhibiting renal, dermatological, neuropsychiatric, and cardiovascular symptoms. In this autoantibodies attack their own organs and immune complex formation occurs as well and ultimately leads to death. Its causes are relatively unknown but complex environmental, genetic, hormonal, and immunological factors are involved in it. This review article summarizes the insights of the past 5 years of research about biomarkers, including activity, monitoring, prognosis, diagnosis, genetic, complement, and traditional biomarkers of SLE with Lupus and neuropsychiatric complications. Our initial search for articles was based on a search from NCBI and PubMed, along with journals from Frontier, Nature Science, and PNAS. Novel Biomarkers in SLE that showed complication with LN and NPSLE are IL-6, IL-16, IL-10, IL-18, IL-1ra, and IL-1b, (cytokine biomarker), Osteopontin (serum biomarker), Lipocalin-2 (NGAL), M-CSF (CSF-1, and M-CSF), Anti-ribosomal P+, VCAM-1, TNF-a, Serum Uric Acid (SUA), Ceruloplasmin, C3 complement components were involved both in NPSLE and LN disease activity of the patients. Also, biomarkers like Angiostatin have shown excellent sensitivity (88%) but poorer specificity (44%) with an AUC value of 0.65 in NPSLE while NLR and PLR showed high sensitivity (90%, 95%) and specificity of (50%, 50%) in LN. We opted for tools that can diagnose, assess disease activity, and predict flares more accurately without conducting an unhealthy process like Biopsy. So this review article is focused on finding the Biomarkers from Blood, Urine, and CSF, with diagnosis, prognosis, and predictive value (Though not clinically validated). It also discusses its use in developing Diagnostics and disease monitoring panels which could further improve SLE diagnosis and assessment of D.A. thus improving the overall patient's condition. However, more thorough research is required due to the general absence of confirmation research among different groups.

Authors

Institutions

Publication Details

Journal
Indus journal of bioscience research.
Published
2025-04-15
DOI
https://doi.org/10.70749/ijbr.v3i4.1017
Primary Topic
Biochemical Acid Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Novel Biomarkers of SLE with Renal and Neuropsychiatry Complications

Fazal Jalil, Muhammad Sohaib, Waseem Iqbal, Muhammad Nawaz et al.
Indus journal of bioscience research.
Biochemical Acid Research Studies
article

Novel Biomarkers of SLE with Renal and Neuropsychiatry Complications

Fazal Jalil, Muhammad Sohaib, Waseem Iqbal, Muhammad Nawaz, Haseena Nazir, Tooba Arshad
article en

Abstract

SLE is a complex multi-organ autoimmune disease exhibiting renal, dermatological, neuropsychiatric, and cardiovascular symptoms. In this autoantibodies attack their own organs and immune complex formation occurs as well and ultimately leads to death. Its causes are relatively unknown but complex environmental, genetic, hormonal, and immunological factors are involved in it. This review article summarizes the insights of the past 5 years of research about biomarkers, including activity, monitoring, prognosis, diagnosis, genetic, complement, and traditional biomarkers of SLE with Lupus and neuropsychiatric complications. Our initial search for articles was based on a search from NCBI and PubMed, along with journals from Frontier, Nature Science, and PNAS. Novel Biomarkers in SLE that showed complication with LN and NPSLE are IL-6, IL-16, IL-10, IL-18, IL-1ra, and IL-1b, (cytokine biomarker), Osteopontin (serum biomarker), Lipocalin-2 (NGAL), M-CSF (CSF-1, and M-CSF), Anti-ribosomal P+, VCAM-1, TNF-a, Serum Uric Acid (SUA), Ceruloplasmin, C3 complement components were involved both in NPSLE and LN disease activity of the patients. Also, biomarkers like Angiostatin have shown excellent sensitivity (88%) but poorer specificity (44%) with an AUC value of 0.65 in NPSLE while NLR and PLR showed high sensitivity (90%, 95%) and specificity of (50%, 50%) in LN. We opted for tools that can diagnose, assess disease activity, and predict flares more accurately without conducting an unhealthy process like Biopsy. So this review article is focused on finding the Biomarkers from Blood, Urine, and CSF, with diagnosis, prognosis, and predictive value (Though not clinically validated). It also discusses its use in developing Diagnostics and disease monitoring panels which could further improve SLE diagnosis and assessment of D.A. thus improving the overall patient's condition. However, more thorough research is required due to the general absence of confirmation research among different groups.

Indus journal of bioscience research.Vol. 3(4)
Abdul Wali Khan University Mardan (PK)
Openalex Percentile: Top 91%
Biochemical Acid Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.